[ACRX] QoQ Quarter Result on 30-Jun-2012 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
09-Aug-2012
Financial Year
2012
Quarter
30-Jun-2012 [#Q2]
Profit Trend
QoQ- -1.83%
YoY- -51.04%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
Revenue 940 1,675 166 224 329 624 408 74.35%
PBT -12,762 -33,363 -8,582 -6,596 -7,065 -20,101 -5,761 69.85%
Tax -1,285 -22,841 390 248 519 -13,728 356 -
NP -12,762 -10,522 -8,582 -7,194 -7,065 -6,372 -5,761 69.85%
Tax Rate - - - - - - - -
Total Cost 13,702 12,197 8,748 7,418 7,394 6,996 6,169 70.15%
Ratio Analysis
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
NP Margin -1,357.66 -628.18 -5,169.88 -3,211.61 -2,147.42 -1,021.15 -1,412.01 -2.58%
Per Share
31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 CAGR
EPS -6.87 -5.67 -7.58 -6.98 -7.21 -6.50 -5.92 10.42%
EPS Diluted -6.87 -5.67 -7.58 -6.98 -7.21 -6.50 -5.92 10.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.